Willem A. Dik

6.4k total citations · 1 hit paper
183 papers, 4.2k citations indexed

About

Willem A. Dik is a scholar working on Immunology, Ophthalmology and Pathology and Forensic Medicine. According to data from OpenAlex, Willem A. Dik has authored 183 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Immunology, 43 papers in Ophthalmology and 33 papers in Pathology and Forensic Medicine. Recurrent topics in Willem A. Dik's work include Ocular Diseases and Behçet’s Syndrome (22 papers), Ophthalmology and Eye Disorders (19 papers) and Glaucoma and retinal disorders (14 papers). Willem A. Dik is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (22 papers), Ophthalmology and Eye Disorders (19 papers) and Glaucoma and retinal disorders (14 papers). Willem A. Dik collaborates with scholars based in Netherlands, Thailand and Indonesia. Willem A. Dik's co-authors include P. Martin van Hagen, L. van Steensel, L de Ruiter, Hessel H. van der Zee, Errol P. Prens, Jon D. Laman, Jacques J. M. van Dongen, Anton W. Langerak, Sita Virakul and Paul Van Daele and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Willem A. Dik

172 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

2011 362 citations Willem A. Dik et al. profile →

Peers

Countries citing papers authored by Willem A. Dik

Since Specialization

Citations

This map shows the geographic impact of Willem A. Dik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willem A. Dik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willem A. Dik more than expected).

Fields of papers citing papers by Willem A. Dik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willem A. Dik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willem A. Dik. The network helps show where Willem A. Dik may publish in the future.

Co-authorship network of co-authors of Willem A. Dik

This figure shows the co-authorship network connecting the top 25 collaborators of Willem A. Dik. A scholar is included among the top collaborators of Willem A. Dik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willem A. Dik. Willem A. Dik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel STAT3 Y360C Gain-of-function Variant Underlies Immune Dysregulation and Aberrancy in Mitochondrial Dynamics 2025 ·Immune Network ·(unknown), (unknown), Zijun Zhou, Virgil A. S. H. Dalm, Fabian Kaiser, Christopher Schliehe, Sigrid Swagemakers, Peter J. van der Spek, Benjamin Schrijver, Petar Vasić, Maaike de Bie, Marleen Bakker, Chiara Milanese, Pier G. Mastroberardino, Nattiya Hirankarn, Narissara Suratannon, Hanna IJspeert, Willem A. Dik, P. Martin van Hagen	1
2	Polarized Macrophages Show Diverse Pro-Angiogenic Characteristics Under Normo- and Hyperglycemic Conditions 2025 ·International Journal of Molecular Sciences ·(unknown), César Payán‐Gómez, Julia Kzhyshkowska, Willem A. Dik, Pieter J. M. Leenen	0
3	Granulomas in Common Variable Immunodeficiency Display Different Histopathological Features Compared to Other Granulomatous Diseases 2024 ·Journal of Clinical Immunology ·(unknown), Jan H. von der Thüsen, Dana A. M. Mustafa, Thierry van den Bosch, (unknown), (unknown), Martin van Hagen, Virgil A. S. H. Dalm, Willem A. Dik, Hanna IJspeert	4
4	T cell induced expression of Coronin-1A facilitates blood-brain barrier transmigration of breast cancer cells 2024 ·Scientific Reports ·Johan M. Kros, (unknown), (unknown), Zineb Belcaid, Willem A. Dik, Theo M. Luider, Dana A. M. Mustafa	0
5	Clinical performance of a novel and rapid bioassay for detection of thyroid-stimulating immunoglobulins in Graves’ orbitopathy patients: a comparison with two commonly used immunoassays 2024 ·Frontiers in Endocrinology ·(unknown), Maaike de Bie, (unknown), (unknown), Roosmarijn C. Drexhage, Sharon Veenbergen, Marjan A. Versnel, P. Martin van Hagen, Dion Paridaens, Willem A. Dik	2
6	Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: Results from a randomized controlled study 2024 ·Journal of Infection ·(unknown), Michiel G.H. Betjes, Willem A. Dik, Ron A. M. Fouchier, Marlies E. J. Reinders, Annelies E. de Weerd	5
7	Polysaccharide, Conjugate, and mRNA-based Vaccines are Immunogenic in Patients with Netherton Syndrome 2024 ·Journal of Clinical Immunology ·(unknown), Luca M. Zaeck, Renske Schappin, Daryl Geers, Lennert Gommers, Susanne Bogers, Willem A. Dik, Suzanne G.M.A. Pasmans, Corine H. GeurtsvanKessel, Rory D. de Vries, Virgil A. S. H. Dalm	1
8	Long-term follow-up after treatment of tubercular uveitis: case series and review of the literature 2023 ·SHILAP Revista de lepidopterología ·Ikhwanuliman Putera, Paul Van Daele, Josianne C. ten Berge, Willem A. Dik, Rina La Distia Nora, P. Martin van Hagen, Saskia M. Rombach	1
9	Diagnosis and biomarkers for ocular tuberculosis: From the present into the future 2023 ·Theranostics ·(unknown), (unknown), Ramar Perumal Samy, Ikhwanuliman Putera, Benjamin Schrijver, Paul Hutchinson, Jayantha Gunaratne, Indu Verma, (unknown), Rina La Distia Nora, P. Martin van Hagen, Willem A. Dik, Vishali Gupta, Rupesh Agrawal	24
10	Altered Functionality of Lipoprotein(a) Impacts on Angiogenesis in Diabetic Retinopathy 2023 ·Investigative Ophthalmology & Visual Science ·(unknown), Nicole M. A. Nagtzaam, (unknown), Conny van Holten-Neelen, Adrie J.M. Verhoeven, Jonas Dehairs, Johannes V. Swinnen, Frank Leijten, Josianne C. ten Berge, (unknown), (unknown), Monique T. Mulder, Pieter J. M. Leenen, Willem A. Dik	4
11	Comparison of two different TSH-receptor antibody assays: A clinical practice study 2023 ·Heliyon ·(unknown), Marco W.J. Schreurs, W. Edward Visser, Robin P. Peeters, Willem A. Dik	7
12	Pentoxifylline as a therapeutic option for pre‐eclampsia: a study on its placental effects 2022 ·British Journal of Pharmacology ·Michelle Broekhuizen, René de Vries, (unknown), Willem A. Dik, Sam Schoenmakers, Birgit C. P. Koch, Daphne Merkus, Irwin Reiss, A.H. Jan Danser, Sinno H. P. Simons, (unknown)	8
13	Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort 2022 ·Lara D. Veeken ·(unknown), Hongchao Qi, Cornelia G van Helden-Meeuwsen, (unknown), (unknown), (unknown), Jens Göpfert, (unknown), (unknown), Marco W.J. Schreurs, Willem A. Dik, Sylvia Kamphuis, Marjan A. Versnel	12
14	COVID-19 in children: Heterogeneity within the disease and hypothetical pathogenesis 2019 ·Asian Pacific Journal of Allergy and Immunology ·Narissara Suratannon, Willem A. Dik, Pantipa Chatchatee, P. Martin van Hagen	15
15	Highlighting the Role of Biomarkers of Inflammation in the Diagnosis and Management of Complex Regional Pain Syndrome 2019 ·Molecular Diagnosis & Therapy ·(unknown), Willem A. Dik, Maaike Dirckx, Frank Huygen	32
16	Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes? 2017 ·Mediators of Inflammation ·(unknown), Maaike Dirckx, Dirk L. Stronks, Willem A. Dik, Marco W.J. Schreurs, Frank Huygen	32
17	Histamine induces NF-κB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1 2016 ·Experimental Eye Research ·Sita Virakul, (unknown), Conny van Holten-Neelen, Benjamin Schrijver, L. van Steensel, Virgil A. S. H. Dalm, Dion Paridaens, Willem A. van den Bosch, P. Martin van Hagen, Willem A. Dik	10
18	PDGF Enhances Orbital Fibroblast Responses to TSHR Stimulating Autoantibodies in Graves' Ophthalmopathy Patients 2012 ·The Journal of Clinical Endocrinology & Metabolism ·L. van Steensel, Herbert Hooijkaas, Dion Paridaens, Willem A. van den Bosch, Robert W. A. M. Kuijpers, Hemmo A. Drexhage, P. Martin van Hagen, Willem A. Dik	34
19	Morbidly Obese Human Subjects Have Increased Peripheral Blood CD4+ T Cells With Skewing Toward a Treg- and Th2-Dominated Phenotype 2012 ·Diabetes ·(unknown), Willem A. Dik, Benjamin Schrijver, Dave H. Schweitzer, Anton W. Langerak, Hemmo A. Drexhage, Rosalie M. Kiewiet, Maarten O. van Aken, Astrid van Huisstede, Jacques J. M. van Dongen, Aart‐Jan van der Lelij, Frank J. T. Staal, P. Martin van Hagen	141
20	Amelioration of renal ischaemia-reperfusion injury by synthetic oligopeptides related to human chorionic gonadotropin 2009 ·Nephrology Dialysis Transplantation ·Nisar Khan, (unknown), Jan Willem van den Berg, Martin Huisman, (unknown), Sandra van den Engel, Henk P. Roest, Jan N.M. IJzermans, Willem A. Dik, R. Benner, Ron W.F. de Bruin	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact